- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04300023
In-home Cycling for Individuals With PD: Feasibility
Examining the Reach, Effectiveness and Maintenance of Social Engagement on Exercise Outcomes: In-home Cycling for Individuals With Parkinson Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The benefits of exercise for individuals with Parkinson disease (PD) have been well documented; however, individuals with PD living in rural and underserved urban settings are largely unable or unwilling to participate in group exercise programs due in large part to their distance from such programs and financial considerations. Additionally, community based programs which provide social support and engagement have been shown to benefit elderly individuals as well as individuals with pathology, but are equally unattainable to this group. Taking the exercise to these individuals via telemedicine or tele-exercise may be an ideal means of delivering this type of intervention.
The long-term goal of this project is to improve outcomes for underserved populations of individuals with Parkinson disease (PD) by providing access to in-home physical activity via a telehealth approach. Approximately one million Americans currently live with a diagnosis of PD and it has been estimated that delaying the progression by 20% would result in a $75,891 savings per individual based on reduced health care costs, income maintenance, increased duration of life and improved quality of life. However, individuals with PD of lower socioeconomic status, people of color and rural dwelling seniors have been critically underserved by clinical and academic programming resulting in poorer health outcomes.
These two studies will examine: 1) the Reach, Effectiveness, Implementation and Maintenance and 2) the optimal delivery method for an in-home exercise intervention program for individuals with PD living in underserved communities. A managed and meaningful exercise intervention will be delivered that not only addresses the benefits of physical activity for individuals with PD, but also offers a social connection to research staff outside of the participant's typical caregiver(s).
Study 1
SPECIFIC AIM 1: Examine the reach and maintenance of an in-home cycling program for underserved individuals with PD. Reach will be assessed by examining the demographic characteristics of the individuals enrolled and through the administration of a questionnaire on objective and subjective socioeconomic status to better understand their level of accessibility to services, perceived barriers and economic status. The investigators will also explore the implementation of a health coach to promote effective maintenance of the program after the 6-month intervention. Finally, two interviews will be conducted to better understand strengths and weakness of the program and to better address the needs of the participants in future studies.
- Hypothesis 1a: Demographic characteristics including race and socioeconomic status of the enrolled participants will not statistically differ from the characteristics of the state of WI.
- Hypothesis 1b: Feedback from participant interviews will inform future delivery of the in-home cycling program.
SPECIFIC AIM 2: Determine the effectiveness of a 6-month in-home, progressive, tele-exercise cycling program and 3-month health coach follow-up for underserved populations of individuals with PD.
- Hypothesis 2a: Participants will improve performance of activities of daily living from baseline to posttest. These effects will be maintained at 3-month follow-up.
- Hypothesis 2b: Participants will significantly improve measures of gait and balance performance and non- significantly improve fall rate from baseline to posttest. These effects will be maintained at 3-month follow-up in the group piloting implementation of a health coach, but not in solo follow-up group. Falls data will allow for effect size calculations for future applications.
- Hypothesis 2c: Activity level as measured by an activity monitor will increase from baseline to posttest. This effect will be maintained at 3-month follow-up in health coach group, but not in the solo group.
Study 2
SPECIFIC AIM 1: Determine whether incorporation of social interaction during physical activity significantly improves task adherence and increases task stamina as compared to solo cycling.
- Hypothesis 1a: Those individuals participating in socially engaged cycling will complete a significantly greater number of cycling sessions than individuals in the solo cycling group.
- Hypothesis 1b: Individuals in the social cycling group will cycle for longer durations at each session than solo cyclists, despite the long term goal being 30 minutes per session for both groups.
SPECIFIC AIM 2: Determine whether incorporation of social interaction during physical activity significantly improves activities of daily living, fall rate and quantity of movement for individuals with PD. The primary variables for this aim are Performance Assessment of Self-care Skills Assessment scores, gait velocity and step count.
- Hypothesis 2a: Socially engaged exercise will result in significantly greater improvement in measures of instrumented activities of daily living (IADL; as measured by the Performance Assessment of Self-care Skills (PASS) assessment) as compared to solo cycling.
- Hypothesis 2b: Fall rate will be non-significantly improved with socially engaged cycling but not with solo cycling. Weekly calls will be placed to both groups to record fall rate. Falls data will allow for effect size calculations for future applications.
- Hypothesis 2c: Overall activity level, as measured by an activity monitor, will increase with socially engaged cycling but not with solo cycling.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kristen A Pickett, PhD
- Phone Number: 608-890-2103
- Email: kristen.pickett@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- Recruiting
- University of Wisconsin
-
Contact:
- Kristen Pickett, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosis of idiopathic "definite PD" based upon established criteria
- vision at or corrected to 20/40 or better
- ability to independently ambulate for at least 10 minutes continuously
- no reported vestibular or neurological disease (stroke or muscle disease) beyond their diagnosed PD
- score of greater than or equal to 78 (no evidence of dementia) on the telephone adaptation of the modified mini-mental state exam
- English Speaking
Exclusion Criteria:
- contraindication for exercise
- history of muscular or orthopedic diagnosis
- inability to participate in the full duration of the study
- currently exercising for 20 or more minutes per week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Study 1: Normal Care Control Group
Study 1: Normal Care Control Group [will crossover and complete the cycling intervention following the initial 6-months]
|
|
Experimental: Study 1: Social Cycling Group
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
|
engaged with a research staff member for 30 minutes of cycling
|
Experimental: Study 2: Social Cycling Group
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
|
engaged with a research staff member for 30 minutes of cycling
|
Experimental: Study 2: Solo Cycling Group
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to cycling without a partner for a target duration and intensity.
|
Exercise without a partner for a target period of time and intensity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Standardized Gait Analysis: Gait Velocity
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
A portable electronic walkway, embedded with sensors, will be used to measure spatiotemporal variables including normalized gait velocity.
Participants will begin at a starting point two meters from the mat, then walk toward and step onto the mat to continue walking until they achieve the stop line located two meters off of the opposite side of the mat.
Data will be collected for forward preferred speed, backward preferred speed, forward fast, tandem and dual task gait.
Each participant will complete five trials for each condition or a minimum of 40 steps
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Functional Gait Analysis: Gait Velocity
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
A portable electronic walkway, embedded with sensors, will be used to measure normalized gait velocity while participants complete a functional shopping task on the instrumented surface.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Canadian Occupational Performance Measure (COPM) scores
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The Canadian Occupational Performance Measure (COPM) will be administered to assess the participant's self-report of performance and satisfaction on a scale of 1 to 10 on self-selected occupational tasks.
Performance and satisfaction scores range from 1 (lowest) to 10 (highest) for each identified item.
The top three identified occupations will be reported.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in mini-BESTest Score
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The mini-BESTest will be used to assess balance.
This 14-item, clinical battery is used to assess balance in four component areas (anticipatory transitions, postural response, sensory orientation and dynamic gait) and provides a single number summary of balance performance.
Scores range from 0 to 28 with higher scores indicate higher function.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) assesses disease progress and clinical symptom presentation in four parts: I - Non-motor experience of daily living; II - Motor experience of daily living; III - Motor; and IV Motor complications.
Scores range from 0 to 199, with 199 indicating most severe.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pittsburgh Sleep Quality Index
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The Pittsburgh Sleep Quality Index measures participant quality of sleep in each of 7 domains over the last month: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction.
The total possible range of scores is 0-21 with 0 indicating no difficulties and 21 indicating severe difficulties.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Timed Up and Go Test
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The Timed Up and Go Test measures the amount of time (in seconds) that it takes for the participant to stand, walk 3 meters away, and return to the seated position.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Activity Level Measured by Number of Steps Taken per day
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The hypothesis is that activity level as measured by an activity monitor will increase from baseline to posttest.
This effect will be maintained at 3-month follow-up in health coach group, but not in the solo group.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Four Square Step Test
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The Four Square Step Test measures the amount of time it takes to step forward, sideways, backward, sideways (and then in the reverse direction back to the start) through the quadrants of a square, stepping over canes that defines its boundaries.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Fall Frequency
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
The Fall History Questionnaire is a 6-item survey that asks about Fall rate in the last 2 weeks, last month, last 6 months, the typical cause of a fall, and how the fear of falling may influence daily activities.
The hypothesis is that Fall frequency will be improved in the socially engaged cycling group and not with those cycling alone.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Free Locomotion Gait Analysis: Time
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Participants will be asked to walk throughout the laboratory space and through nearby ground-floor hallways outside the laboratory, while wearing miniature wearable sensors to record their motion.
Sensors record time, acceleration, angular velocity, magnetic field, air pressure (altitude), and optionally relative distance.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Free Locomotion Gait Analysis: Acceleration
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Participants will be asked to walk throughout the laboratory space and through nearby ground-floor hallways outside the laboratory, while wearing miniature wearable sensors to record their motion.
Sensors record time, acceleration, angular velocity, magnetic field, air pressure (altitude), and optionally relative distance.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Free Locomotion Gait Analysis: Angular Velocity
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Participants will be asked to walk throughout the laboratory space and through nearby ground-floor hallways outside the laboratory, while wearing miniature wearable sensors to record their motion.
Sensors record time, acceleration, angular velocity, magnetic field, air pressure (altitude), and optionally relative distance.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Change in Free Locomotion Gait Analysis: Relative Distance
Time Frame: baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Participants will be asked to walk throughout the laboratory space and through nearby ground-floor hallways outside the laboratory, while wearing miniature wearable sensors to record their motion.
Sensors record time, acceleration, angular velocity, magnetic field, air pressure (altitude), and optionally relative distance.
|
baseline, post-test (~6-months), 3-month follow up (~9-months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kristen A Pickett, PhD, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-0414: Feasibility
- A176000 (Other Identifier: University of Wisconsin, Madison)
- 1UL1TR002373-01 (U.S. NIH Grant/Contract)
- EDUC\KINESIOLOGY\KINESIO (Other Identifier: UW Madison)
- 1KL2TR002374-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Social Cycling Group
-
Chinese University of Hong KongThe Hong Kong Jockey Club Charities TrustUnknown
-
University Medical Centre LjubljanaSlovenian Research AgencyUnknownKidney Diseases | Chronic Kidney Diseases | Physical Activity | End Stage Renal Disease | Kidney FailureSlovenia
-
Chinese University of Hong KongInnovation and Technology Commission, Hong KongRecruiting
-
Somogy Megyei Kaposi Mór Teaching HospitalUniversity of GroningenCompletedHealthy | Parkinson Disease | Movement Disorders | ConditionHungary
-
San Diego State UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Karolinska InstitutetThe Swedish Research Council; Region Stockholm; Stiftelsen Sunnerdahls Handikappfond and other collaboratorsCompletedDepression | Anxiety | Attention Deficit Hyperactivity Disorder (ADHD) | Autism Spectrum Disorder (ASD)Sweden
-
Holland Bloorview Kids Rehabilitation HospitalUniversity of Alberta; University of Toronto; Dalhousie University; IWK Health... and other collaboratorsRecruitingAutism Spectrum Disorder | Social Communication Disorder | Autism-Related Speech Delay | Autism Spectrum Disorder With Impaired Functional Language | Autism or Autistic TraitsCanada
-
Karolinska InstitutetMarcus och Amalia Wallenbergs minnesfondCompletedDepression | Anxiety | Autism Spectrum Disorder | Attention Deficit Hyperactivity DisorderSweden
-
University of MichiganCompleted
-
National Taiwan University HospitalCompletedAutism Spectrum DisorderTaiwan